NCT04205279Recruiting
Reactive Balance Training for Fall Prevention
Reactive Balance Training for Fall Prevention: a Comparative Study of Three Different Perturbation Devices
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The objective of this pilot study is to evaluate and compare the effect of three different perturbation based training devices on the reactive balance control among healthy young adults, healthy older adults, and neurologically impaired stroke individuals. Furthermore, the project aims to determine the feasibility and tolerability of 30-minutes of perturbation training using the SureFooted Trainer. Overall, the project directs to find out the long term effect of training on fall risk reduction and fall prevention. This study investigates the effects of perturbation training (slip and trip) based on the principles of motor learning. Perturbations in the form of slips and trips induced by the three different types of perturbation devices will displace the center of mass outside the base of support and challenge the stability, thereby inducing a fall and demand compensatory strategies in order to prevent it. Such perturbation training would train the motor system to improve stability control and vertical limb support. The project design aims to examine the ability of the central nervous system to mitigate the interference in stability control (if any) that is induced by opposing types of perturbations. The hypothesis of this study if supported by the results, will provide the difference in motor learning with training on three different perturbation devices. Furthermore, it would help to determine which of the three training devices is the most effective in developing defense mechanisms necessary to reduce fall-risk among community-living older adults and the neurological population.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 11 Dec 2019
- Start date
- 1 Feb 2018
- Primary completion date
- 31 May 2027
- Lead sponsor
- University of Illinois Chicago
- Diseases
- Stroke
- NCT number
- NCT04205279
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 1 Feb 2018 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with mild cognitive impairment (Mini-mental State Exam score \< 25/30) will be excluded.
- Body weight more than 250 lbs.
- Persons with stroke:
- Individuals with mild cognitive impairment (Mini-mental State Exam score \< 25/30) will be excluded.
Age
- Subjects will not proceed with the test if any of the following occurs at baseline measurement: 1) HR \> 85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age), 2) systolic blood pressure (SBP) \> 165 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg during resting), and 3) oxygen saturation (measured by pulse oximeter) during resting \< 95%.
- Subjects will not proceed with the test if any of the following occurs at baseline measurement: 1) HR \> 85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age), 2) systolic blood pressure (SBP) \> 165 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg during resting), and 3) oxygen saturation (measured by pulse oximeter) during resting \< 95%.
- 6 minute walk test. Subjects will also be screened out if on the 6 minute walk test they complain of shortness of breath or uncontrolled pain (\> 3/10 on VAS) or pulse oxygen drops \< 92% or are unable to achieve the age-specified minimal ambulation distance.
- Subjects will not proceed with the test if any of the following occurs at baseline measurement: 1) HR \> 85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age), 2) systolic blood pressure (SBP) \> 165 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg during resting), and 3) oxygen saturation (measured by pulse oximeter) during resting \< 95%.
- 6 minute walk test. Subjects will also be screened out if on the 6 minute walk test they complain of shortness of breath or uncontrolled pain (\> 3/10 on VAS) or pulse oxygen drops \< 92% or are unable to achieve the age-specified minimal ambulation distance.
Other
- Healthy subject:
- Body weight more than 250 lbs.
- Healthy Older adults:
- Individuals with heel bone density with a T-score \< -2, is classified as osteoporotic and will be excluded.
- Individuals with heel bone density with a T-score \< -2, is classified as osteoporotic and will be excluded.
- Body weight more than 250 lbs.
Who the study is looking for
- Healthy Young participants
- Age group: 18-55 years.
- Absence of any acute or chronic neurological, cardiopulmonary, musculoskeletal or systemic diagnosis.
- No recent major surgery (\< 6 months) or hospitalization (\< 3 months)
- Not on any sedative drugs.
- Can understand and communicate in English
- Healthy older adults
- Age group: 56-90 years.
- Absence of any acute or chronic neurological, cardiopulmonary, musculoskeletal or systemic diagnosis.
- No recent major surgery (\< 6 months) or hospitalization (\< 3 months)
- Not on any sedative drugs.
- Ability to walk with or without an assistive device for 10 meters
- Can understand and communicate in English
- Berg balance scale score \<45/56.
- Persons with stroke
- Age group: 18-90 years.
- Absence of any acute or chronic neurological diagnosis except stroke (self reported)
- Onset of stroke (\> 6 months)
- Absence of any cardiopulmonary, musculoskeletal or systemic diagnosis.
- No recent major surgery (\< 6 months) or hospitalization (\< 3 months)
- Not on any sedative drugs.
- Ability to walk with or without an assistive device for 10 meters
- Can understand and communicate in English
Age in the registry: 18 years to 90 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Illinois at Chicago Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.